Clinical Trials Browser

Has results × Esophageal Neoplasms × regorafenib × Clear all

NCT01913639 2020-05-15

FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer

Phase 2 Completed

39 enrolled 11 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms